Wayment-Steele, Hannah K. http://orcid.org/0000-0003-4949-2010
Kladwang, Wipapat
Watkins, Andrew M.
Kim, Do Soon
Tunguz, Bojan
Reade, Walter http://orcid.org/0000-0002-9215-700X
Demkin, Maggie
Romano, Jonathan http://orcid.org/0000-0003-4031-0102
Wellington-Oguri, Roger
Nicol, John J.
Gao, Jiayang http://orcid.org/0000-0003-0650-2581
Onodera, Kazuki
Fujikawa, Kazuki http://orcid.org/0000-0002-0372-689X
Mao, Hanfei http://orcid.org/0000-0001-6319-3581
Vandewiele, Gilles http://orcid.org/0000-0001-9531-0623
Tinti, Michele http://orcid.org/0000-0002-0051-017X
Steenwinckel, Bram
Ito, Takuya
Noumi, Taiga
He, Shujun
Ishi, Keiichiro
Lee, Youhan
Öztürk, Fatih
Chiu, King Yuen http://orcid.org/0000-0001-6438-8479
Öztürk, Emin
Amer, Karim
Fares, Mohamed http://orcid.org/0000-0003-3600-3716
Das, Rhiju http://orcid.org/0000-0001-7497-0972
,
Funding for this research was provided by:
Stanford University (RISE)
U.S. Department of Health & Human Services | National Institutes of Health (R35 GM122579)
Article History
Received: 14 October 2021
Accepted: 21 October 2022
First Online: 14 December 2022
Competing interests
: D.S.K., W.K. and R.D. hold equity in a new venture seeking to stabilize mRNA molecules, and D.S.K. and W.K. are employees of that venture. W.R. and M.D. are employees of Kaggle. The remaining authors declare no competing interests.